107 related articles for article (PubMed ID: 19798)
1. [EEG records and effects of phenothiazine treatment in patients with paranoid schizophrenia].
Ekiert H; Gogol Z; Welbel L; Kazubska M
Psychiatr Pol; 1977; 11(3):325-33. PubMed ID: 19798
[No Abstract] [Full Text] [Related]
2. [Pipothiazine (piportil) in the treatment of various forms of schizophrenia].
Matkowski K; Sep-Kowalikowa B
Psychiatr Pol; 1979; 13(4):421-3. PubMed ID: 42095
[No Abstract] [Full Text] [Related]
3. [Pimozide and piportil in the treatment of chronic schizophrenia (preliminary communication)].
Masiak M; Majczak A; Hascewicz-Rzecka M; Kowalczyk A
Psychiatr Pol; 1976; 10(6):655-60. PubMed ID: 13443
[No Abstract] [Full Text] [Related]
4. Piperacetazine in ambulatory chronic schizophrenic patients.
Rada RT; Donlon PT
Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
[No Abstract] [Full Text] [Related]
5. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
[No Abstract] [Full Text] [Related]
6. Huntington's disease masquerading as chronic schizophrenia.
Van Putten T; Menkes JH
Dis Nerv Syst; 1973 Jan; 34(1):54-6. PubMed ID: 4145383
[No Abstract] [Full Text] [Related]
7. [Use of systematic organization of the EEG in the diagnosis of psychopathologic states].
Bochkarev VK; Nikiforov AI; Danilenko IuM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(12):1805-11. PubMed ID: 6141688
[TBL] [Abstract][Full Text] [Related]
8. [EEG performance spectral mapping during drug therapy in a patient with schizophrenic psychosis].
Schellenberg R; Schwarz A; Knorr W; Schindler M
Psychiatr Neurol Med Psychol (Leipz); 1990 Oct; 42(10):618-24. PubMed ID: 1981811
[TBL] [Abstract][Full Text] [Related]
9. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
[TBL] [Abstract][Full Text] [Related]
10. [Haloperidol decanoate in replacing combinations of antipsychotic agents in the treatment of chronic schizophrenics].
Youssef HA
Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):297-304. PubMed ID: 6152573
[No Abstract] [Full Text] [Related]
11. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
Termińska K; Mrowiec W
Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of various graphometric methods in the evaluation of the neuroleptic threshold].
Pobocha J
Ann Acad Med Stetin; 1978; 24():549-64. PubMed ID: 33585
[No Abstract] [Full Text] [Related]
13. Recording automatic and controlled information processing by means of bioelectrical brain signals in normals and paranoid schizophrenics with and without neuroleptic medication.
Krieger S; Bertling R; Schweizer A; Tegeler J
Pharmacopsychiatry; 1988 Nov; 21(6):331-3. PubMed ID: 2907639
[No Abstract] [Full Text] [Related]
14. [About the curability of schizophrenia].
Gaszner P
Neuropsychopharmacol Hung; 2005 Mar; 7(1):39-42. PubMed ID: 16167467
[TBL] [Abstract][Full Text] [Related]
15. [Paranoid schizophrenia: free amino acids in the cerebrospinal fluid].
Prieto-Rincón D; Piñerúa-Shuhaibar L; Bonilla E; Prasad A; Arrieta A
Invest Clin; 1991; 32(4):149-55. PubMed ID: 1688037
[TBL] [Abstract][Full Text] [Related]
16. Spectrum analysis of the EEG in schizophrenic patients.
Vanderheeren F; Van Rompu E; Jannes C; Delaunois AL
Arzneimittelforschung; 1979; 29(9):1437-9. PubMed ID: 42419
[TBL] [Abstract][Full Text] [Related]
17. [Indications for long-term neuroleptic medication--standard procedure or individual prognosis-guided intervention? A prospective study of the clinical treatment model].
Gaebel W; Pietzcker A
Nervenarzt; 1983 Sep; 54(9):467-76. PubMed ID: 6138719
[No Abstract] [Full Text] [Related]
18. Conditioning in the prediction of drug withdrawal effects in chronic schizophrenic patients.
Ban TA; Ananth JV; Lehmann HE
Act Nerv Super (Praha); 1974 Mar; 16(1):23-33. PubMed ID: 4156144
[No Abstract] [Full Text] [Related]
19. [Natural evolution of paranoid schizophrenia treated consecutively with 4 different neuroleptics].
Portier A; Sarfati Y
Encephale; 2000; 26(4):75-7. PubMed ID: 11064844
[TBL] [Abstract][Full Text] [Related]
20. Switch to ziprazidone treatment is associated with changes in MMN amplitude: a case report.
Salazar J; Ordoño F; Soriano S; Rueda M; Ojeda E; Cozar R; Belloch V
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):573-4. PubMed ID: 19439243
[No Abstract] [Full Text] [Related]
[Next] [New Search]
